Keywords: pharmagene, starts, ph, ii, trial, pgn0052, uk

Pharmagene starts Ph II trial of PGN0052

Article | 22 December 2003

Print This

Pharmagene of the UK has initiated a Phase II proof-of-principle trialof its PGN0052, a synthetic version of human secretin, for ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in